Target intelligence / Profile preview

Fungal pathogen cell wall component

Molecular classification
Other (complex carbohydrate polymer), Enzyme (biosynthetic enzymes such as glucan synthase and chitin synthase are also considered molecular targets), Structural protein (adhesins and mannoproteins)
01

Overview

Fungal pathogen cell wall components form a multilayered, dynamic exoskeleton surrounding fungal cells. The main polymers are β-1,3-glucan, chitin, and mannan, often cross-linked and attached to glycoproteins. The structural scaffold provides cell shape, integrity, and protection against environmental stresses and immune attack. Fungal cell wall elements are absent in human cells, making them attractive antifungal drug targets. Key enzymes involved in biosynthesis—such as β-D-glucan synthase and chitin synthase—are therapeutic targets. Clinical antifungals like echinocandins disrupt cell wall architecture, leading to cell lysis and death. Fungi may develop resistance through cell wall remodeling (e.g., increased chitin), underlining the importance of ongoing research into cell wall molecular biology, adaptations, and new drug targets.

Other names
Fungal cell wallPathogenic fungal cell wallFungal cell wall polysaccharidesFungal wall glycoproteinsFungal cell wall structure
02

Mechanism of action

Inhibition of β-1,3-glucan synthesis (echinocandins, ibrexafungerp) Inhibition of chitin synthesis (nikkomycin) Inhibition of GPI anchor biosynthesis (fosmanogepix) Disruption of adhesion (targeting cell wall surface proteins)

03

Biological functions

Cell integrityCell protectionImmune evasionHost colonization (adhesion)Cellular morphogenesisVirulence
04

Disease associations

InfectionAntifungal drug resistanceImmune evasionOther (e.g., facilitating colonization and invasion)
05

Safety considerations

Emerging antifungal resistance (modification/adaptation of cell wall composition)Host toxicity (generally lower due to fungal-specific structure, but off-target effects possible)Immunosuppression (patients susceptible to fungal infections often immunocompromised; efficacy may be lower)
06

Interacting drugs

Echinocandins (e.g., caspofungin, micafungin, anidulafungin—target β-1,3-glucan synthesis)

3 more in the full profile.

07

Biomarkers

Serum β-1,3-glucan (marker of invasive fungal infection)Mannan antigen

Beyond the preview

Go deeper on Fungal pathogen cell wall component.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fungal pathogen cell wall component.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call